Logo image of HBANL

HUNTINGTON BANCSHARES - HBAN 6 7/8 PERP (HBANL) Stock Fundamental Analysis

NASDAQ:HBANL - Nasdaq - US4461507737

25.4  -0.19 (-0.74%)

Fundamental Rating

2

Overall HBANL gets a fundamental rating of 2 out of 10. We evaluated HBANL against 405 industry peers in the Banks industry. Both the profitability and financial health of HBANL have multiple concerns. HBANL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HBANL was profitable.
In the past year HBANL had a positive cash flow from operations.
HBANL had positive earnings in 4 of the past 5 years.
HBANL had a positive operating cash flow in 4 of the past 5 years.
HBANL Yearly Net Income VS EBIT VS OCF VS FCFHBANL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B

1.2 Ratios

HBANL's Return On Assets of 0.76% is in line compared to the rest of the industry. HBANL outperforms 45.98% of its industry peers.
HBANL has a Return On Equity (7.37%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.76%
ROE 7.37%
ROIC N/A
ROA(3y)0.93%
ROA(5y)0.92%
ROE(3y)9.12%
ROE(5y)8.84%
ROIC(3y)N/A
ROIC(5y)N/A
HBANL Yearly ROA, ROE, ROICHBANL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 21.22%, HBANL perfoms like the industry average, outperforming 44.47% of the companies in the same industry.
HBANL's Profit Margin has declined in the last couple of years.
HBANL does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 21.22%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y18.35%
PM growth 5Y-3.39%
GM growth 3YN/A
GM growth 5YN/A
HBANL Yearly Profit, Operating, Gross MarginsHBANL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1

2. Health

2.1 Basic Checks

HBANL does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for HBANL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HBANL Yearly Shares OutstandingHBANL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B
HBANL Yearly Total Debt VS Total AssetsHBANL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50B 100B 150B

2.2 Solvency

HBANL has a debt to FCF ratio of 11.20. This is a negative value and a sign of low solvency as HBANL would need 11.20 years to pay back of all of its debts.
HBANL has a worse Debt to FCF ratio (11.20) than 73.62% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that HBANL is somewhat dependend on debt financing.
HBANL has a worse Debt to Equity ratio (0.57) than 79.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 11.2
Altman-Z N/A
ROIC/WACCN/A
WACC12.52%
HBANL Yearly LT Debt VS Equity VS FCFHBANL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HBANL Yearly Current Assets VS Current LiabilitesHBANL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2

3. Growth

3.1 Past

HBANL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.71%.
HBANL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.32% yearly.
EPS 1Y (TTM)-10.71%
EPS 3Y-1.55%
EPS 5Y-0.32%
EPS Q2Q%13.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.63%

3.2 Future

HBANL is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.00% yearly.
Based on estimates for the next years, HBANL will show a small growth in Revenue. The Revenue will grow by 3.94% on average per year.
EPS Next Y9.55%
EPS Next 2Y11.32%
EPS Next 3Y2.25%
EPS Next 5Y6%
Revenue Next Year5.81%
Revenue Next 2Y5.33%
Revenue Next 3Y3.33%
Revenue Next 5Y3.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
HBANL Yearly Revenue VS EstimatesHBANL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
HBANL Yearly EPS VS EstimatesHBANL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.32, HBANL is valued on the expensive side.
HBANL's Price/Earnings ratio is a bit more expensive when compared to the industry. HBANL is more expensive than 77.89% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.96. HBANL is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 18.55, HBANL is valued on the expensive side.
HBANL's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HBANL is more expensive than 75.38% of the companies in the same industry.
HBANL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.11, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 20.32
Fwd PE 18.55
HBANL Price Earnings VS Forward Price EarningsHBANL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

79.15% of the companies in the same industry are cheaper than HBANL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 35.04
EV/EBITDA N/A
HBANL Per share dataHBANL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HBANL does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)2.13
PEG (5Y)N/A
EPS Next 2Y11.32%
EPS Next 3Y2.25%

4

5. Dividend

5.1 Amount

HBANL has a Yearly Dividend Yield of 3.68%.
HBANL's Dividend Yield is a higher than the industry average which is at 3.24.
HBANL's Dividend Yield is rather good when compared to the S&P500 average which is at 2.29.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

The dividend of HBANL has a limited annual growth rate of 5.35%.
HBANL is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)5.35%
Div Incr Years1
Div Non Decr Years1
HBANL Yearly Dividends per shareHBANL Yearly Dividends per shareYearly Dividends per share 2023 2024 0.5 1 1.5

5.3 Sustainability

HBANL pays out 68.97% of its income as dividend. This is not a sustainable payout ratio.
The dividend of HBANL is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP68.97%
EPS Next 2Y11.32%
EPS Next 3Y2.25%
HBANL Yearly Income VS Free CF VS DividendHBANL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B
HBANL Dividend Payout.HBANL Dividend Payout, showing the Payout Ratio.HBANL Dividend Payout.PayoutRetained Earnings

HUNTINGTON BANCSHARES - HBAN 6 7/8 PERP

NASDAQ:HBANL (1/17/2025, 8:05:33 PM)

25.4

-0.19 (-0.74%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-17 2025-01-17/bmo
Earnings (Next)N/A N/A
Inst Owners85.57%
Inst Owner ChangeN/A
Ins Owners1.07%
Ins Owner ChangeN/A
Market Cap36.90B
Analysts76.3
Price Target30.14 (18.66%)
Short Float %0%
Short Ratio1.46
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend0.72
Dividend Growth(5Y)5.35%
DP68.97%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.59%
Min EPS beat(2)4.87%
Max EPS beat(2)8.31%
EPS beat(4)4
Avg EPS beat(4)8.23%
Min EPS beat(4)4.87%
Max EPS beat(4)9.94%
EPS beat(8)8
Avg EPS beat(8)6.22%
EPS beat(12)9
Avg EPS beat(12)1.85%
EPS beat(16)11
Avg EPS beat(16)2.27%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-1.63%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-3.99%
Max Revenue beat(4)-0.63%
Revenue beat(8)1
Avg Revenue beat(8)-1.1%
Revenue beat(12)3
Avg Revenue beat(12)-1.08%
Revenue beat(16)4
Avg Revenue beat(16)-0.66%
PT rev (1m)11.81%
PT rev (3m)0.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.45%
EPS NY rev (1m)0%
EPS NY rev (3m)1.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.39%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)0.11%
Valuation
Industry RankSector Rank
PE 20.32
Fwd PE 18.55
P/S 5.16
P/FCF 35.04
P/OCF 30.03
P/B 1.79
P/tB 2.56
EV/EBITDA N/A
EPS(TTM)1.25
EY4.92%
EPS(NY)1.37
Fwd EY5.39%
FCF(TTM)0.72
FCFY2.85%
OCF(TTM)0.85
OCFY3.33%
SpS4.92
BVpS14.18
TBVpS9.92
PEG (NY)2.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 7.37%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 21.22%
GM N/A
FCFM 14.72%
ROA(3y)0.93%
ROA(5y)0.92%
ROE(3y)9.12%
ROE(5y)8.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y18.35%
PM growth 5Y-3.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 11.2
Debt/EBITDA N/A
Cap/Depr 24.04%
Cap/Sales 2.46%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 69.37%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC12.52%
ROIC/WACCN/A
Cap/Depr(3y)41.64%
Cap/Depr(5y)37.02%
Cap/Sales(3y)2.99%
Cap/Sales(5y)2.75%
Profit Quality(3y)158.46%
Profit Quality(5y)150.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.71%
EPS 3Y-1.55%
EPS 5Y-0.32%
EPS Q2Q%13.33%
EPS Next Y9.55%
EPS Next 2Y11.32%
EPS Next 3Y2.25%
EPS Next 5Y6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13.63%
Revenue Next Year5.81%
Revenue Next 2Y5.33%
Revenue Next 3Y3.33%
Revenue Next 5Y3.94%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.48%
EBIT Next 3Y10.04%
EBIT Next 5YN/A
FCF growth 1Y-63.84%
FCF growth 3Y27.87%
FCF growth 5Y9.27%
OCF growth 1Y-61.19%
OCF growth 3Y26.17%
OCF growth 5Y9.01%